| 10.15 0.15 (1.5%) | 09-25 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.17 | 1-year : | 14.35 |
| Resists | First : | 11.28 | Second : | 12.28 |
| Pivot price | 10.21  |
|||
| Supports | First : | 9.64 | Second : | 8.02 |
| MAs | MA(5) : | 9.99  |
MA(20) : | 10.62 |
| MA(100) : | 10.41 |
MA(250) : | 13.69 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 18.1 |
D(3) : | 11.1 |
| RSI | RSI(14): 41.3 |
|||
| 52-week | High : | 24.24 | Low : | 7.76 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PHR ] has closed above bottom band by 43.5%. Bollinger Bands are 45% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 10.26 - 10.3 | 10.3 - 10.34 |
| Low: | 9.85 - 9.89 | 9.89 - 9.94 |
| Close: | 10.08 - 10.15 | 10.15 - 10.22 |
Phreesia, Inc. offers a comprehensive, cloud-based software-as-a-service (SaaS) and payment platform specifically designed for the healthcare industry in the United States and Canada. Its flagship Phreesia Platform streamlines the patient intake process and facilitates integrated patient payment processing. The platform is accessible via multiple modalities, including Phreesia Mobile (a patient-facing mobile application), Phreesia Dashboard (a web-based portal for healthcare clients), self-service tablets known as PhreesiaPads, and on-site Arrivals Kiosks. The Phreesia Platform integrates a suite of specialized modules: An automated patient self-registration system. A revenue cycle management solution providing insurance verification, point-of-sale payment applications, and cost estimation tools. Access solutions for online appointment scheduling, reminders, and referral tracking. A life sciences solution delivering targeted, clinically relevant marketing content to patients. Additionally, a clinical support solution gathers clinical intake and patient-reported outcome (PRO) data across approximately 25 specialties, and enables healthcare clients to communicate with patients via surveys, announcements, text and email messaging, and health campaigns. Dedicated COVID-19 support modules assist with vaccine delivery management, identifying vaccine-hesitant individuals, screening for risk factors, facilitating contactless check-in, and managing telehealth visit intake. Phreesia serves a diverse clientele, including individual patients; single and multi-specialty practices, along with health systems; and pharmaceutical, medical device, and biotechnology firms. Established in 2005, the company maintains its headquarters in Raleigh, North Carolina.
Tue, 22 Sep 2026
Phreesia (NYSE: PHR) HR chief reports 2,876-share tax withholding - Stock Titan
Tue, 22 Sep 2026
Phreesia (PHR) president has 4,476 shares withheld for taxes - Stock Titan
Tue, 22 Sep 2026
Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR - Eastern Progress
Tue, 22 Sep 2026
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Eastern Progress
Mon, 21 Sep 2026
Phreesia Inc. (PHR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Eastern Progress
Mon, 21 Sep 2026
Planned Phreesia (NYSE: PHR) insider stock sale tops $67K - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 62 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 6.2 (%) |
| Held by Institutions | 96.1 (%) |
| Shares Short | 2,710 (K) |
| Shares Short P.Month | 3,520 (K) |
| EPS | 0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.8 |
| Profit Margin | 2 % |
| Operating Margin | 5.8 % |
| Return on Assets (ttm) | 2.5 % |
| Return on Equity (ttm) | 3.1 % |
| Qtrly Rev. Growth | 10.3 % |
| Gross Profit (p.s.) | 5.52 |
| Sales Per Share | 8.18 |
| EBITDA (p.s.) | 0.7 |
| Qtrly Earnings Growth | 200 % |
| Operating Cash Flow | 91 (M) |
| Levered Free Cash Flow | 68 (M) |
| PE Ratio | 56.38 |
| PEG Ratio | 0 |
| Price to Book value | 1.74 |
| Price to Sales | 1.24 |
| Price to Cash Flow | 6.89 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|